Results 101 to 110 of about 2,293 (174)

Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM [PDF]

, 2016
OBJECTIVE: Key augmented processes in atherosclerosis have been identified, whereas less is known about downregulated pathways. Here, we applied a systems biology approach to examine suppressed molecular signatures, with the hypothesis that they may ...
Aldi, S, Baldassarre, D, de Faire, U, Diez, MG, Ehrenborg, E, Ericsson, I, Eriksson, P, Hamsten, A, Hansson, GK, Hedin, U, Humphries, SE, Jin, H, Kronqvist, M, Lehtio, J, Lengquist, M, Li, Y, Lindeman, JHN, Maegdefessel, L, Magne, J, Matic, LP, Miller, CL, Odeberg, J, Paloschi, V, Paulsson-Berne, G, Quertermous, T, Razuvaev, A, Rohl, S, Roy, J, Rykaczewska, U, Sabater-Lleal, M, Tremoli, E, Veglia, F, Vesterlund, M, Vukojevic, V   +33 more
core  

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Ariketa fisikoa eta mina zein funtzio mailaren arteko erlazioa. Errebisio sistematikoa. [PDF]

, 2017
[EUS] Ikerketa honek sistematikoki errebisatu zuen ariketa fisikoak minarengan zein funtzioan duen eragina. Artikuluen bilaketa PUBMED eta GOOGLE SCHOLAR datu base elektronikoetan egin zen, baita errebisioan sartzen ez ziren errebisio sistematikoetako ...
Gorritxategi Basauri, Peru
core  

Sjögren-Larsson syndrome: Anesthetic considerations and practical recommendations. [PDF]

Paediatr Anaesth, 2020
Franzen MH, LeRiger MM, Pellegrino KP, Kugler JA, Rizzo WB.   +4 more
europepmc   +1 more source

Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome. [PDF]

Mol Cell Biol, 2021
Nojiri K, Fudetani S, Arai A, Kitamura T, Sassa T, Kihara A.   +5 more
europepmc   +1 more source

Sjögren-Larsson syndrome in Spain: Description of three new cases

Anales de Pediatría (English Edition), 2021
Cristina Villar-Vera, Ana Cuesta Peredo, Lucía Monfort-Belenguer, María Rosario Abellán Sanchez, Cecilia Martínez-Costa   +4 more
doaj   +1 more source

The emerging role of the endocannabinoid system in cardiovascular disease [PDF]

, 2018
Endocannabinoids are endogenous bioactive lipid mediators present both in the brain and various peripheral tissues, which exert their biological effects via interaction with specific G-protein-coupled cannabinoid receptors, the CB1 and CB2.
Pacher, Pál, Steffens, Sabine
core  

EHA2024 Hybrid Congress

HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome. [PDF]

J Inherit Metab Dis, 2020
Staps P, Rizzo WB, Vaz FM, Bugiani M, Giera M, Heijs B, van Kampen AHC, Pras-Raves ML, Breur M, Groen A, Ferdinandusse S, van der Graaf M, Van Goethem G, Lammens M, Wevers RA, Willemsen MAAP.   +15 more
europepmc   +1 more source

Do you know this syndrome? Sjogren-Larsson syndrome.

Anais brasileiros de dermatologia, 2011
We report a typical case of Sjogren-Larsson syndrome in a male patient, aged 20. The Sjogren-Larsson syndrome is a neurocutaneous, autosomal recessive and disabling condition, characterized by congenital ichthyosis, spastic paraplegia and mental retardation. It is caused by deficiency of the microsomal enzyme fatty aldehyde dehydrogenase.
Marcela Duarte Villela, Benez, Elisa, Fontenelle, Brunela Bastos, Tozzi, Carolina, Presotto   +3 more
openaire   +1 more source